Press Releases

Jun 2, 2026

Jordan Park

Press Releases

Constellation Brands to Report First Quarter Fiscal 2027 Financial Results on June 30, 2026 After Market Close and Host Conference Call on July 1, 2026 at 8:00 am ET

Constellation Brands, a leading beverage alcohol producer and marketer, will report its Q1 fiscal 2027 financial results on June 30, 2026, after market close, followed by a conference call on July 1. The company plans to discuss its financial performance, strategic initiatives, and outlook during the call, highlighting its diverse portfolio of beer…

STZ

Jun 2, 2026

Hana Yamamoto

Press Releases

Hubbell Incorporated Prices $1.9 Billion Senior Notes Offering

Hubbell Incorporated announced the successful pricing of a $1.9 billion senior notes offering consisting of fixed-rate notes due in 2031, 2033, and 2036. Proceeds will be used to finance the proposed acquisition of NSI Electrical Buyer, repay NSI's debt, cover transaction costs, and for general corporate purposes. The offering is expected to close …

HUBB

Jun 2, 2026

Maya Rios

Press Releases

Alvotech to present at upcoming investor conferences in June

Alvotech, a biotechnology company specializing in biosimilar medicines, announced that its Founder and Executive Chairman Robert Wessman, along with Chief Strategy Officer Dr. Balaji V. Prasad, will participate in investor conferences in June 2026 including Jefferies, Goldman Sachs, and UBS events. The presentations will be webcast live and recorde…

ALVO

Jun 2, 2026

Nina Shah

Press Releases

Tenaya Therapeutics to Announce New Interim Data from MyPEAK™-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated HCM on Wednesday, June 3, 2026

Tenaya Therapeutics will present new interim data from cohorts 1 and 2 of the Phase 1b/2 MyPEAK-1 trial evaluating TN-201, a gene therapy aimed at treating adults with MYBPC3-associated hypertrophic cardiomyopathy (HCM). The company highlights TN-201’s potential to address the genetic root cause of this severe heart condition through a single intra…

TNYA

Jun 2, 2026

Hana Yamamoto

Press Releases

Village Farms Announces Election of Directors and Results of Annual Meeting of Shareholders

Village Farms International, Inc. reported the results of its annual shareholder meeting held on June 2, 2026. All proposed matters, including the election of directors, were approved by a majority of votes. The company reaffirmed its leadership election, reappointment of KPMG LLP as auditor, and plans to file detailed results with regulators.

VFF

Jun 2, 2026

Maya Rios

Press Releases

Neuronetics Appoints Robert Greene as Senior Vice President Sales

Neuronetics, Inc., a US-based medical technology company specializing in neurohealth products, announced the appointment of Robert Greene as Senior Vice President Sales effective June 1, 2026. Greene brings extensive experience in healthcare sales and will receive restricted stock units as part of his compensation. The company focuses on NeuroStar …

STIM

Jun 2, 2026

Sofia Navarro

Press Releases

ATN International, Inc. Completes Initial Closing on the Sale of its Towers and Updates 2026 Outlook

ATN International, Inc. announced the initial closing of its $268 million sale of Southwestern U.S. towers to Everest Infrastructure Partners. Proceeds will strengthen liquidity and reduce debt. The sale is expected to lower 2026 revenue, operating income, and Adjusted EBITDA, causing the firm to revise its 2026 Adjusted EBITDA guidance downward to…

ATNI

Jun 2, 2026

Jordan Park

Press Releases

Xos Launches the 2.5MWh Power Hub, Delivering Grid-Independent Energy Storage to Data Centers in Days, Not Years

Xos, Inc. has introduced the 2.5MWh Power Hub series, a factory-integrated, rapidly deployable energy storage and hybrid power system designed to deliver megawatt-scale power within days, bypassing traditional 3 to 7 year US grid interconnection delays. Built on a proven platform with over 250 MWh deployed across North America, the Power Hub target…

XOS

Jun 2, 2026

Hana Yamamoto

Press Releases

Crescent Biopharma to Present at June Investor Conferences

Crescent Biopharma, a clinical-stage biotechnology company focused on cancer therapies, announced that its management will present at the 2026 Jefferies Global Healthcare Conference and the Goldman Sachs 47th Annual Global Healthcare Conference in June 2026. The presentations will be webcast live and replayed on the company's investor website.

CBIO

Jun 2, 2026

Caleb Monroe

Press Releases

Abundia Global Impact Group to Participate in the 16th Annual ROTH London Conference

Abundia Global Impact Group, a NYSE American-listed company specializing in converting biomass and plastics waste into low-carbon fuels, announced its participation in the upcoming 16th Annual ROTH London Conference. The Company will use this platform to discuss advances in its Cedar Port project, commercialization strategies, feedstock and technic…

AGIG

Jun 2, 2026

Marcus Reed

Press Releases

Microchip Technology to Present at the 2026 Evercore Global TMT Conference

Microchip Technology Incorporated, a leading embedded control solutions provider, announced it will present at the 2026 Evercore Global TMT Conference. The presentation will feature the CEO and CFO discussing company insights and outlook. A live webcast will be available for investors and stakeholders.

MCHP

Jun 2, 2026

Caleb Monroe

Press Releases

Crinetics and Leading Patient Groups Launch ‘Everyday Advocacy’ Initiative to Empower People Across Endocrine Disease Communities

Crinetics Pharmaceuticals, a US-based biotech firm specializing in endocrine disorders, has launched 'Everyday Advocacy,' a patient-centered program providing education, support, and tools to empower individuals with endocrine and related conditions. Developed in collaboration with leading patient organizations, the initiative aims to improve patie…

CRNX

Jun 2, 2026

Nina Shah

Press Releases

PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.0833 per Share

PennantPark Floating Rate Capital Ltd., a business development company investing primarily in U.S. middle-market private companies, announced its monthly distribution for June 2026 at $0.0833 per share. This distribution includes a base dividend and a supplemental dividend and is expected to be paid from taxable net investment income.

PFLT

Jun 2, 2026

Avery Klein

Press Releases

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Orchestra BioMed announced inducement grants of stock options totaling 85,500 shares to five newly hired employees as part of its 2025 New Hire Inducement Plan, complying with Nasdaq Listing Rule 5635(c)(4). The stock options vest over four years. The company is advancing two flagship biomedical products, AVIM Therapy and Virtue Sirolimus AngioInfu…

OBIO

Jun 2, 2026

Hana Yamamoto

Press Releases

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Fate Therapeutics, a clinical-stage biopharmaceutical company specializing in iPSC-derived cellular immunotherapies, announced it awarded restricted stock units totaling 67,300 shares to two newly-hired non-executive employees as an inducement to join the company. The RSUs will vest over four years. This action follows Nasdaq Listing Rule 5635(c)(4…

FATE

Jun 2, 2026

Priya Menon

Press Releases

PetMeds® Announces Fourth Quarter and Fiscal Year 2026 Financial Results

PetMed Express, Inc. (NASDAQ: PETS) announced its fourth quarter and full fiscal year 2026 financial results, reporting a significant decline in net sales primarily due to decreased prescription medication sales. The company reported a net loss of $57.3 million for the full year, a substantial increase compared to the prior year, driven by goodwill…

PETS

Jun 2, 2026

Avery Klein

Press Releases

Sportsman’s Warehouse Holdings, Inc. Announces First Quarter 2026 Financial Results

Sportsman’s Warehouse Holdings, Inc. announced financial results for Q1 fiscal 2026, showing a 2.8% increase in net sales driven by growth in Hunting and Shooting Sports and Fishing categories. Despite economic headwinds and higher fuel prices, same-store sales rose 2.1%. The company improved e-commerce sales by over 6% and focused on disciplined c…

SPWH

Jun 2, 2026

Derek Hwang

Press Releases

Netskope Joins Anthropic’s Project Glasswing

Netskope (NASDAQ: NTSK) has joined Anthropic's Project Glasswing, leveraging Anthropic’s advanced AI model, Mythos Preview, to detect vulnerabilities in code swiftly and at scale. This collaboration enhances Netskope's ability to provide real-time governance and security across AI applications and enterprise traffic, addressing critical gaps in AI …

NTSK

Jun 2, 2026

Marcus Reed

Press Releases

TransUnion Named 2026 Media and Entertainment Snowflake Product Partner of the Year

TransUnion has been named the 2026 Media and Entertainment Snowflake Product Partner of the Year, recognizing its rapid adoption of cloud-native identity resolution and enrichment solutions on the Snowflake data platform. This partnership enables clients to process billions of records securely within Snowflake’s environment, enhancing data trust, p…

TRU

Jun 2, 2026

Sofia Navarro

Press Releases

Duos Technologies Receives $50.4 Million from APR Energy Asset Sale

Duos Technologies Group, Inc. announced receipt of approximately $50.4 million from the sale of substantially all assets of New APR Energy, where Duos holds a 5% non-voting interest. This capital infusion bolsters Duos' financial position and supports its strategic focus on core technology and Edge AI initiatives.

DUOT

Jun 2, 2026

Leila Farooq

Press Releases

Vaxcyte Doses First Participant in Phase 1 Study Evaluating VAX-A1 for the Prevention of Disease Caused by Group A Streptococcus in Healthy Adults

Vaxcyte, Inc. announced the dosing of the first participant in its Phase 1 clinical trial evaluating VAX-A1, a novel vaccine candidate designed to prevent diseases caused by Group A Streptococcus (Group A Strep). This dose-escalation study aims primarily to assess safety and tolerability, with secondary evaluation of immune response in healthy adul…

PCVX

Jun 2, 2026

Caleb Monroe

Press Releases

Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution

Cue Biopharma announced key changes to its board of directors as part of its strategic evolution toward becoming a late-stage clinical company. Four independent directors resigned, and the company appointed Daniel Camardo, an experienced CEO with commercial launch success, and Viola Meehan, a seasoned CFO with extensive finance and governance exper…

CUE

Jun 2, 2026

Avery Klein

Press Releases

BriaCell Therapeutics Announces Closing of Offering

BriaCell Therapeutics Corp., a clinical-stage biotechnology company focused on cancer immunotherapies, announced the closing of a best-efforts offering of approximately 1.45 million common shares at $3.25 per share, raising gross proceeds of about $4.7 million. The funds will be used for working capital, general corporate purposes, and advancing bu…

BCTX

Jun 2, 2026

Marcus Reed

Press Releases

NRx Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock

NRx Pharmaceuticals, a clinical-stage biopharmaceutical company focusing on CNS disorders, announced its intention to offer common stock through an underwritten public offering. The company aims to use the proceeds for working capital and general corporate purposes. The offering is subject to market conditions and includes an option for underwriter…

NRXP

Jun 2, 2026

Derek Hwang

Press Releases

Syndax Highlights Revuforj® (revumenib) Data Presented at ASCO 2026, Including an Oral Presentation of Post-Transplant Data

Syndax Pharmaceuticals showcased new data at ASCO 2026 demonstrating favorable outcomes for Revuforj (revumenib) as maintenance therapy post hematopoietic stem cell transplant in patients with high-risk acute leukemias. The pooled analysis of 24 patients revealed a 90% two-year overall survival, nearly doubling the historical benchmark of 51%. Addi…

SNDX